I
About the Company
Uses high-throughput biological testing and AI to predict which chemotherapy drugs will work best for specific cancer patients
Industry Sector
BioTech
Tech Stack
Machine Learning
Flow Cytometry
Personalized Medicine AI
Product
A diagnostic report for veterinarians that ranks the effectiveness of different drug options based on the patient's live cancer cells.
View ProductStartup Details
Investment Stage
Series A
Cumulative Investment
$10M - $50M
Activity Region
North America